Results for tag: "Systemic Mastocytosis Drug"

Systemic Mastocytosis (SM) is a rare disorder of the immune system caused by an abnormal increase in mast cells. It is characterized by the presence of mast cells in the skin, bone marrow, and other organs. Treatment of SM is based on the severity of the symptoms and the organs affected. Drugs used to treat SM include antihistamines, corticosteroids, and mast cell stabilizers. In more severe cases, chemotherapy and targeted therapies may be used. The Systemic Mastocytosis Drug market is a niche market within the larger Immune Disorders Drugs market. It is composed of a variety of drugs used to treat SM, including antihistamines, corticosteroids, mast cell stabilizers, chemotherapy, and targeted therapies. Some companies in the Systemic Mastocytosis Drug market include Novartis, Pfizer, Merck, and Sanofi. Show Less Read more